Literature DB >> 9505964

In vitro recombination of feline herpesvirus type 1.

K Fujita1, K Maeda, N Yokoyama, T Miyazawa, C Kai, T Mikami.   

Abstract

We investigated the possibility of in vitro recombination of three different strains of feline herpesvirus type 1 (FHV-1), a virulent strain (C7805), a vaccine strain (F2), and a candidate vaccine strain with a deletion in the thymidine kinase gene (C7301dlTK). The results showed that recombination within different genotypes of FHV-1 strains could occur at a relatively high frequency ranging from 10.1% to 21.5% in vitro. These results indicate the generation of multiple mutant viruses by in vitro recombination experiments. The possibility for generating a virulent virus or novel type of FHV-1 by recombination in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9505964     DOI: 10.1007/s007050050265

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  10 in total

1.  A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.

Authors:  Geoffrey A Peters; Shaun D Tyler; Charles Grose; Alberto Severini; Michael J Gray; Chris Upton; Graham A Tipples
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Genetic Diversity of Infectious Laryngotracheitis Virus during In Vivo Coinfection Parallels Viral Replication and Arises from Recombination Hot Spots within the Genome.

Authors:  Carlos A Loncoman; Carol A Hartley; Mauricio J C Coppo; Paola K Vaz; Andrés Diaz-Méndez; Glenn F Browning; Maricarmen García; Stephen Spatz; Joanne M Devlin
Journal:  Appl Environ Microbiol       Date:  2017-11-16       Impact factor: 4.792

3.  The equine herpesvirus-1 (EHV-1) IR3 transcript downregulates expression of the IE gene and the absence of IR3 gene expression alters EHV-1 biological properties and virulence.

Authors:  Byung Chul Ahn; Yunfei Zhang; Dennis J O'Callaghan
Journal:  Virology       Date:  2010-04-24       Impact factor: 3.616

4.  Interspecific recombination between two ruminant alphaherpesviruses, bovine herpesviruses 1 and 5.

Authors:  François Meurens; Günther M Keil; Benoît Muylkens; Sacha Gogev; Frédéric Schynts; Sandra Negro; Laetitia Wiggers; Etienne Thiry
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  Divergence and recombination of clinical herpes simplex virus type 2 isolates.

Authors:  Peter Norberg; Mabula J Kasubi; Lars Haarr; Tomas Bergström; Jan-Ake Liljeqvist
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

6.  Rise and survival of bovine herpesvirus 1 recombinants after primary infection and reactivation from latency.

Authors:  Frédéric Schynts; François Meurens; Bruno Detry; Alain Vanderplasschen; Etienne Thiry
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.

Authors:  Maricarmen García; Joanne M Devlin; Carlos A Loncoman; Carol A Hartley; Mauricio J C Coppo; Glenn F Browning; Gabriela Beltrán; Sylva Riblet; Carolina O Freitas
Journal:  Appl Environ Microbiol       Date:  2018-11-15       Impact factor: 4.792

8.  Superinfection prevents recombination of the alphaherpesvirus bovine herpesvirus 1.

Authors:  François Meurens; Frédéric Schynts; Günther M Keil; Benoît Muylkens; Alain Vanderplasschen; Pierre Gallego; Etienne Thiry
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Rad51 and Rad52 are involved in homologous recombination of replicating herpes simplex virus DNA.

Authors:  Ka-Wei Tang; Peter Norberg; Martin Holmudden; Per Elias; Jan-Åke Liljeqvist
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

10.  Low genetic diversity among historical and contemporary clinical isolates of felid herpesvirus 1.

Authors:  Paola K Vaz; Natalie Job; Jacquelyn Horsington; Nino Ficorilli; Michael J Studdert; Carol A Hartley; James R Gilkerson; Glenn F Browning; Joanne M Devlin
Journal:  BMC Genomics       Date:  2016-09-02       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.